INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01FWFogarty Patrick W0B / 206S206 trades$1.10M
  2. 02Kurtz George0B / 202S202 trades$48.06M
  3. 03SPSaba Capital Management, L.P.67B / 19S · 11 late86 trades$21.51M
  4. 04NYNissan Yitzhak82B / 0S · 79 late82 trades$2.61M
  5. 05ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  6. 06AJAllaire Jeremy0B / 50S50 trades$4.26M
  7. 07Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  8. 08SJSheena Jonathan0B / 45S45 trades$3.01M
  9. 09SISarowitz Steven I2B / 34S36 trades$21.18M
  10. 10SLSpeiser Michael L0B / 35S35 trades$14.00M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 1732 insiders$917K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 179 insiders$893K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 178 insiders$2.77M
  7. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

73,372 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
FW
Frazier WilliamDirector, Chief Medical Officer
VMDVIEMED HEALTHCARE, INC.
Option exercise
M—
850 sh
Jan 21, 2026Jan 23, 2026
Page 1458 of 1835
← PrevNext →
traded Jan 21, 2026
+2d
SEC Form 4

Evidence

9
BR
Bensoussan Torres RobertDirector
IPARINTERPARFUMS INC
Option exercise
M—
375 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

9
VA
Velleca Mark A.Director, PRESIDENT & CEO
BDTXBlack Diamond Therapeutics, Inc.
Grant or award
A—
600.0K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
JJ
Jones Jeffrey J IIDirector
LEVILEVI STRAUSS & CO
Grant or award
A—
2,067 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
FE
Forrestel Richard E JrDirector
CHMGCHEMUNG FINANCIAL CORP
Grant or award
A$34K
591 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
WH
Weber James HarryExecutive Vice President
CMACOMERICA INC
Option exercise
M$29K
543 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

9
SI
Stefan Constantin IonelChief Technology Officer
AMPXAmprius Technologies, Inc.
Option exercise
M$33K
72.8K sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

9
WH
Weber James HarryExecutive Vice President
CMACOMERICA INC
Option exercise
M—
1,335 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

9
BR
Bensoussan Torres RobertDirector
IPARINTERPARFUMS INC
Option exercise
M—
375 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

9
SI
Stefan Constantin IonelChief Technology Officer
AMPXAmprius Technologies, Inc.
Option exercise
M$26K
41.6K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
FT
Fitzgerald TraeChief Financial Officer
VMDVIEMED HEALTHCARE, INC.
Disposition to issuer
D$25K
3,329 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
HG
Harrison GilbertDirector
IPARINTERPARFUMS INC
Option exercise
M—
375 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

9
CJ
Cambre JeromeVice President of Sales
VMDVIEMED HEALTHCARE, INC.
Tax withholding
F$29K
3,827 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
SI
Stefan Constantin IonelChief Technology Officer
AMPXAmprius Technologies, Inc.
Option exercise
M$8,305
166.1K sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

9
FT
Fitzgerald TraeChief Financial Officer
VMDVIEMED HEALTHCARE, INC.
Option exercise
M—
3,329 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
OA
Ortiz Mauricio AEVP & Chief Accounting Officer
CMACOMERICA INC
Option exercise
M$44K
650 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

9
OA
Ortiz Mauricio AEVP & Chief Accounting Officer
CMACOMERICA INC
Option exercise
M—
975 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

9
HG
Harrison GilbertDirector
IPARINTERPARFUMS INC
Option exercise
M—
375 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

9
SL
Spikner Pamela L.SVP Controller & CAO
BDXBECTON DICKINSON & CO
Tax withholding
F—
84 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
TJ
Thompson Amanda JChief People Officer
GAPGAP INC
Disposition to issuer
D—
3,034 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

9
KC
Kulkarni Sandeep ChidambarDirector, Chief Executive Officer
ZURAZura Bio Ltd
Grant or award
A—
2.93M sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$421K
3,350 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

9
HC
Hoyt CaseyDirector, Chief Executive Officer
VMDVIEMED HEALTHCARE, INC.
Option exercise
M—
12.4K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
BR
Bensoussan Torres RobertDirector
IPARINTERPARFUMS INC
Option exercise
M—
375 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

9
OA
Ortiz Mauricio AEVP & Chief Accounting Officer
CMACOMERICA INC
Option exercise
M—
650 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

9
TD
Townsell DonnaDirector, Director of Investor Relations
HOMBHOME BANCSHARES INC
Option exercise
M—
20.0K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
FW
Frazier WilliamDirector, Chief Medical Officer
VMDVIEMED HEALTHCARE, INC.
Disposition to issuer
D$6,367
850 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
DD
Dillard George Douglas JrDirector
AYIACUITY INC. (DE)
Grant or award
A—
546 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
AB
Alexander Victor BHead of Consumer Bank
KEYKEYCORP /NEW/
Option exercise
M—
9,345 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
OA
Ortiz Mauricio AEVP & Chief Accounting Officer
CMACOMERICA INC
Option exercise
M—
1,285 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

9
SI
Stefan Constantin IonelChief Technology Officer
AMPXAmprius Technologies, Inc.
Option exercise
M—
15.8K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
WH
Weber James HarryExecutive Vice President
CMACOMERICA INC
Option exercise
M—
2,130 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

9
SI
Stefan Constantin IonelChief Technology Officer
AMPXAmprius Technologies, Inc.
Option exercise
M—
15.9K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
WH
Weber James HarryExecutive Vice President
CMACOMERICA INC
Option exercise
M—
940 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

9
CJ
Cambre JeromeVice President of Sales
VMDVIEMED HEALTHCARE, INC.
Disposition to issuer
D$22K
2,930 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
KR
Kushel J. RichardSenior Managing Director
BLKBlackRock, Inc.
Option exercise
M—
20.0K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
HG
Harrison GilbertDirector
IPARINTERPARFUMS INC
Option exercise
M—
375 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

9
BM
Brennan Ita MDirector
PLPlanet Labs PBC
Option exercise
M—
423 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
JE
Jones ErikaSEE REMARKS
BDTXBlack Diamond Therapeutics, Inc.
Grant or award
A—
200.0K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
JM
Joshi ManherChief Development Officer
SLNOSOLENO THERAPEUTICS INC
Grant or award
A—
4,700 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence